EDT Matinas BioPharma (MTNB) files to sell 16.9M shares of common stock for holdersStay Ahead of the Market: Discover outperforming ...

Matinas BioPharma's gross profit margin for fiscal years ending December 2019 to 2023 averaged -13,422.8%. Matinas BioPharma's operated at median gross profit margin of -8,968.8% from fiscal years ...

Shares of Matinas Biopharma Holdings, Inc. (NYSE:MTNB – Get Free Report) fell 6.6% during mid-day trading on Tuesday .The company traded as low as $0.53 and last traded at $0.56. 46,870 shares ...

In a recent Special Meeting held on Monday, Matinas BioPharma (NYSE:MTNB) Holdings, Inc. received shareholder approval on several significant proposals. The meeting, which was convened on April 4, ...

In a recent Special Meeting held on Monday, Matinas BioPharma (NYSE:MTNB) Holdings, Inc. received shareholder approval on several significant proposals. The meeting, which was convened on April 4 ...

BioNTech saw its share price increase by 11%, coinciding with significant market activity and major index gains. While the company itself did not have any significant news or announcements within ...

BioNTech has shown why it made small cell lung cancer (SCLC) a priority for its PD-L1xVEGF-A bispecific. The biotech linked BNT327 to a median overall survival (OS) of 16.8 months in a Chinese ...

Backers, including BioNTech, have committed around one-third of the targeted IPO haul. China’s DualityBio filed to go public in Hong Kong last year but let that submission lapse. Having added ...

FORT LAUDERDALE, FL / ACCESS Newswire / April 21, 2025 / Sunshine Biopharma Inc. (NASDAQ:SBFM), a pharmaceutical company offering and researching life-saving medicines in a variety of therapeutic ...

Novavax recipients had 1.7 symptoms on average vs. 2.8 for Pfizer-BioNTech in SHIELD-Utah. 24.2% of Novavax recipients had Grade 2+ symptoms vs. 43.8% of Pfizer-BioNTech recipients. Markets are ...

Toronto, Ontario--(Newsfile Corp. - April 18, 2025) - Quantum BioPharma Ltd. (QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of ...